KardiaMobile 6L for measuring cardiac QT interval in people having antipsychotic medication
Closed for comments This consultation ended on at Request commenting lead permission
2 The technology
The technology
2.1 KardiaMobile 6L (AliveCor) 6-lead, handheld, electrocardiogram (ECG) device.
The comparator
2.2 12-lead ECG device.
Clinical need
2.3 People taking antipsychotic medication may need to have tests for cardiac abnormalities before starting treatment and at regular intervals during treatment. Detecting cardiac abnormalities such as prolonged QT interval can inform choice of therapy, dosing, whether to stop therapy, and potentially avoid severe cardiac events.
2.4 QT interval is usually measured using a 12-lead ECG device to record the ECG. This needs the person to partially undress and use conductive gel on the skin to create contact with the electrodes. This can cause reluctance and distress. An ECG is recorded in primary or secondary care centres.
2.5 The KardiaMobile 6L allows ECG recording with less need for undressing and without using conductive gel. KardiaMobile 6L ECG can be recorded during a routine home visit by a community health professional. This may reduce stress and anxiety.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions